Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lifeline Biotechnologies developed non-invasive diagnostic devices aimed at early identification of breast tissue abnormalities and direct visualization tools for breast and ovarian cancers. Its First Warning System underwent multiple rounds of clinical trials showing promise in early abnormality identification. In 2017–2018, core technology was transferred to Cyrcadia, Inc., which continued product development and clinical validation at major US hospitals. Positive interim results were reported from one-third completion of pivotal trials at El Camino Hospital and Ohio State University Cancer Center
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lifeline Biotechnologies.